Looks good, but comes with the usual proviso, "further investigation" required.
The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study.
Mult Scler. 2007 May;13(4):517-26. Epub 2007 Feb 9.
Zabad RK, Metz LM, Todoruk TR, Zhang Y, Mitchell JR, Yeung M, Patry DG,
Bell RB, Yong VW.
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
Minocycline has immunomodulatory and neuroprotective activities in vitro and in an ...